Hero Background

EULAR 2024 Conference: Insights and Analysis

  • Home
  • EULAR Conference 2024

Our Recent Articles

Types / Technology


Indications


Case Studies

Market Assessment

Market Assessment

Find out how a global pharma company evaluated the market potential of asset gained through acquisition

R&D Landscape Assessment

R&D Landscape Assessment

Discover how the large pharma client develops API and FD using CDMO competence

KOL Profiling

KOL Profiling

Learn how the engagement with respected KOLs bolstered the client's reputation as a leader in the pharma industry

Due Diligence

Due Diligence

Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics

Competitive Intelligence News Monitoring

Competitive Intelligence News Monitoring

Explore how thorough CI news monitoring helps the client to make proactive decisions that align with their business objectives.

Newsletter and Whitepapers

Rheumatoid Arthritis

Rheumatoid Arthritis: Dominating TNF Inhibitors, Soaring Biosimilars, and Safety Profile of JAK Inhibitors

Over the past few years, a dramatic improvement in outcomes of rheumatoid arthritis has been observed due to the direct consequence of paradigm shifts in the treatment. Conventional DMARDs (csDMARDS) and methotrexate (MTX) are part of the first treatment strategy. Learn about the recent happenings, ongoing research & development, and significant pharmaceutical companies involved in the rheumatoid arthritis treatment market.

Latest Reports

Acute Gout Flare
Chronic Gout Market
Chronic Refractory Gout
Lupus Nephritis Market
Osteoarthritis
Polymyalgia Rheumatica Market Insight, Epidemiology And Market Forecast - 2032
Polymyositis - Market Insight, Epidemiology And Market Forecast - 2032
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Gout

Get Expert Consultation Now!

Our extensive history and deep knowledge in the field of rheumatology make us an ideal ally for addressing your urgent business challenges.

Leveraging our comprehensive understanding of the rheumatology pipeline, nuanced grasp of market dynamics, and keen insight into marketing intricacies, we can assist you in devising a highly effective strategy for future success.

Reach out to us to explore potential collaboration opportunities and learn more about the valuable solutions we can provide.

Delivering value through our expansive service offerings

Considering the ever-changing nature of the rheumatology therapy field, it's crucial to establish a competitive advantage for your business as soon as possible. Our range of consulting services and market research resources positions us well to guide you through obstacles while maximizing your strengths and opportunities.

We provide valuable insights to enhance your competitive edge and develop successful growth strategies. Join us on a journey to uncover opportunities and avoid pitfalls, as we simplify the process of optimizing your return on investment through our expert guidance.

Involve us to help you collect insights on which asset could hold the most potential in the future.

Our 11-year forecast provides foresight for effective strategy-building for successful market entry

Our research expertise delivers real-time information that elevates your business decisions

We assist in navigating the tricky drug development terrain by providing intelligence assessments